Olema Pharmaceuticals
OLMA
OLMA
130 hedge funds and large institutions have $700M invested in Olema Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 42 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
+2
Holders Change %
+1.56%
% of All Funds
1.88%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
47
Reduced
42
Closed
17
Calls
$2.87M
Puts
$286K
Net Calls
+$2.59M
Net Calls Change
+$1.13M
Top Buyers
| 1 |
Pictet Asset Management
Carouge,
Switzerland
|
+$19.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$13.4M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$8.47M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.99M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.68M |
Top Sellers
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
-$28.7M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$10.8M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$4.39M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$4.16M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.68M |
